Login / Signup
Tommy Mandagi
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Climate Change
Pluripotent Stem Cells
Hepatitis C Virus
Mycobacterium Tuberculosis
Top Venues
BioMed research international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Otman Siregar
,
Aznan Lelo
,
Ahmad Jabir Rahyussalim
,
Syafruddin Ilyas
,
Benny
,
Trie Kurniawati
,
Yohanes Augustinus
,
Hendra
,
Tommy Mandagi
,
Muhammad Luqman Labib Zufar
,
Irfan Fathurrahman
Doxycycline as a Potential MMP-1 Inhibitor for the Treatment of Spondylitis Tuberculosis: A Study in Rabbit Model.
BioMed research international
2023 (2023)
Otman Siregar
,
Aznan Lelo
,
Ahmad Jabir Rahyussalim
,
Syafruddin Ilyas
,
Benny
,
Trie Kurniawati
,
Yohanes Augustinus
,
Hendra
,
Tommy Mandagi
,
Muhammad Luqman Labib Zufar
,
Irfan Fathurrahman
Doxycycline as a Potential MMP-1 Inhibitor for the Treatment of Spondylitis Tuberculosis: A Study in Rabbit Model.
BioMed research international
2023 (2023)
Otman Siregar
,
Aznan Lelo
,
Ahmad Jabir Rahyussalim
,
Syafruddin Ilyas
,
Benny
,
Trie Kurniawati
,
Yohanes Augustinus
,
Hendra
,
Tommy Mandagi
,
Muhammad Luqman Labib Zufar
,
Irfan Fathurrahman
Doxycycline as a Potential MMP-1 Inhibitor for the Treatment of Spondylitis Tuberculosis: A Study in Rabbit Model.
BioMed research international
2023 (2023)